Detailed Drug Information:

DRUG CLASS AND MECHANISM: Saquinavir is an oral medication that is used for treating infections with the human immunodeficiency virus (HIV). It is in a class of drugs called protease inhibitors which also includes indinavir (Crixivan), nelfinavir (Viracept) and ritonavir (Norvir). During infection with HIV, the HIV virus multiplies within thebody's cells. Viruses are released from the cells and spread throughout the body where they infect other cells. In this manner, HIVinfection is perpetuated among new cells that the body produces continually. During the production of the viruses, new proteins aremade. Some of the proteins are structural proteins, that, is, proteins that form the body of the virus. Other proteins are enzymes whichmanufacture DNA and other components for the new viruses. Protease is the enzyme that forms the new structural proteins andenzymes. Saquinavir blocks the activity of protease and results in the formation of defective viruses that are unable to infect the body'scells. As a result, the number of viruses in the body (the viral load) decreases. Nevertheless, saquinavir does not prevent thetransmission of HIV among individuals, and it does not cure HIV infections or AIDS. Saquinavir was approved by the FDA in December, 1995.

PREPARATIONS: Capsules: 200 mg

STORAGE: Refrigerate Fortovase capsules at 2-8°C(36-46°F). When stored at room temperature, Fortovase capsules expire within 90 days.

Store Invirase capsules at room temperature, 15-30°C (59-86°F).

PRESCRIBED FOR: Saquinavir is used for the treatment of HIV infection.

DOSING: The recommended dose of Invirase for adults is 600 mg three times daily, and the dosage forFortovase is 1200 mg three times daily. Both formulations should be administered within 2 hours of a meal.

DRUG INTERACTIONS: Saquinavir interacts with many drugs. Some of the important interactions are mentionedbelow. Viewers should consult their healthcare provider before combining any drugs with saquinavir.

Saquinavir should not be used together with triazolam (Halcion), midazolam (Versed), sildenafil (Viagra) and ergotamine derivatives (e.g. Ergostat) because saquinavir increases the concentration of these drugs in the body and this could cause serious side effects.

Saquinavir also may inhibit the break-down of the cholesterol-lowering drugs lovastatin (Mevacor), simvastatin (Zocor), atorvastatin (Lipitor) and cerivastatin (Baycol). Combining saquinavir with these drugs may increase the occurrence of muscle breakdown(rhabdomyolysis) which is seen when these drugs accumulate in the body.

Clarithromycin (Biaxin) and ketoconazole (Nizoral) may increase bloodconcentrations of saquinavir and cause increased severity or frequency of side effects from saquinavir. Saquinavir also increases the concentration of clarithromycin.

Rifampin (Rifadin) and rifabutin (Mycobutin) decrease blood concentrations of saquinavir and therefore could decrease the effectiveness of saquinavir.

PREGNANCY: Use of saquinavir during pregnancy has not been adequately evaluated.

NURSING MOTHERS: It is not known whether saquinavir is secreted in breast milk. Nevertheless, HIV-infectedmothers should not breast-feed because of the potential risk of transmitting HIV to an infant that is not infected.

SIDE EFFECTS: The most frequent side effects are headache, weakness, diarrhea, nausea and stomach discomfort. Saquinavir also may cause skin reactions, liver failure, seizures and failure of thepancreas (pancreatitis). Like other protease inhibitors, use of saquinavir may be associated with redistribution or accumulation of body fat, increased cholesterol and worsening of diabetes.